Parnaparin sodium

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	B01AB07 (WHO)
Identifiers
CAS Number	9041-08-1 Y
DrugBank	DB09260 Y
ChemSpider	none
UNII	U6K360XMIU
KEGG	D04977
(verify)

Parnaparin is anantithrombotic and belongs to the group oflow molecular weight heparins. In the prevention and therapy of thromboembolic pathologies, the advent of this class of drugs represented a medical development, since they retain the same effectiveness of unfractionated heparin but with simpler dosing regimens and decreased side effects. In addition to being effective in treating proven deep vein thrombosis and thrombosis-associated phlebopathies, Parnaparin has demonstrated its thromboprophylactic efficacy in both high- and moderate-risk surgical patients.

• parnaparin at the U.S. National Library of MedicineMedical Subject Headings (MeSH)
• Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C (2007). "Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood".Thromb. Haemost.97 (6):965–73.doi:10.1160/th06-12-0680.PMID 17549299.S2CID 24068001.

Thisdrug article relating to theblood andblood forming organs is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Heparins
• Blood and blood forming organ drug stubs

• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Chemicals that do not have a ChemSpider ID assigned
• Articles without EBI source
• Articles without InChI source
• Drugs with no legal status
• All stub articles